vs
Astrana Health, Inc.（ASTH）与Fair Isaac（FICO）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是Fair Isaac的1.9倍（$950.5M vs $512.0M），Fair Isaac净利率更高（30.9% vs 0.7%，领先30.2%），Astrana Health, Inc.同比增速更快（42.9% vs 16.4%），Fair Isaac自由现金流更多（$173.9M vs $-6.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 8.6%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
FICO（原Fair, Isaac and Company）是美国知名数据分析企业，1956年由比尔·费尔与厄尔·艾萨克创立，总部位于蒙大拿州博兹曼市，核心业务为信用评分服务，其推出的FICO信用分是评估消费者信贷风险的重要指标，目前已被美国消费信贷行业广泛采用。
ASTH vs FICO — 直观对比
营收规模更大
ASTH
是对方的1.9倍
$512.0M
营收增速更快
ASTH
高出26.5%
16.4%
净利率更高
FICO
高出30.2%
0.7%
自由现金流更多
FICO
多$179.8M
$-6.0M
两年增速更快
ASTH
近两年复合增速
8.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $512.0M |
| 净利润 | $6.6M | $158.4M |
| 毛利率 | — | 83.0% |
| 营业利润率 | 1.9% | 45.7% |
| 净利率 | 0.7% | 30.9% |
| 营收同比 | 42.9% | 16.4% |
| 净利润同比 | 184.4% | 3.8% |
| 每股收益（稀释后） | $0.12 | $6.61 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHFICO
| Q4 25 | $950.5M | $512.0M | ||
| Q3 25 | $956.0M | $515.8M | ||
| Q2 25 | $654.8M | $536.4M | ||
| Q1 25 | $620.4M | $498.7M | ||
| Q4 24 | $665.2M | $440.0M | ||
| Q3 24 | $478.7M | $453.8M | ||
| Q2 24 | $486.3M | $447.8M | ||
| Q1 24 | $404.4M | $433.8M |
净利润ASTHFICO
| Q4 25 | $6.6M | $158.4M | ||
| Q3 25 | $373.0K | $155.0M | ||
| Q2 25 | $9.4M | $181.8M | ||
| Q1 25 | $6.7M | $162.6M | ||
| Q4 24 | $-7.8M | $152.5M | ||
| Q3 24 | $16.1M | $135.7M | ||
| Q2 24 | $19.2M | $126.3M | ||
| Q1 24 | $14.8M | $129.8M |
毛利率ASTHFICO
| Q4 25 | — | 83.0% | ||
| Q3 25 | — | 82.3% | ||
| Q2 25 | — | 83.7% | ||
| Q1 25 | — | 82.4% | ||
| Q4 24 | — | 80.1% | ||
| Q3 24 | — | 80.3% | ||
| Q2 24 | — | 80.3% | ||
| Q1 24 | — | 80.0% |
营业利润率ASTHFICO
| Q4 25 | 1.9% | 45.7% | ||
| Q3 25 | 2.0% | 46.0% | ||
| Q2 25 | 3.1% | 48.9% | ||
| Q1 25 | 3.3% | 49.3% | ||
| Q4 24 | 0.1% | 40.8% | ||
| Q3 24 | 5.9% | 43.4% | ||
| Q2 24 | 6.2% | 42.5% | ||
| Q1 24 | 7.5% | 44.9% |
净利率ASTHFICO
| Q4 25 | 0.7% | 30.9% | ||
| Q3 25 | 0.0% | 30.1% | ||
| Q2 25 | 1.4% | 33.9% | ||
| Q1 25 | 1.1% | 32.6% | ||
| Q4 24 | -1.2% | 34.7% | ||
| Q3 24 | 3.4% | 29.9% | ||
| Q2 24 | 3.9% | 28.2% | ||
| Q1 24 | 3.7% | 29.9% |
每股收益（稀释后）ASTHFICO
| Q4 25 | $0.12 | $6.61 | ||
| Q3 25 | $0.01 | $6.41 | ||
| Q2 25 | $0.19 | $7.40 | ||
| Q1 25 | $0.14 | $6.59 | ||
| Q4 24 | $-0.14 | $6.14 | ||
| Q3 24 | $0.33 | $5.44 | ||
| Q2 24 | $0.40 | $5.05 | ||
| Q1 24 | $0.31 | $5.16 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $162.0M |
| 总债务越低越好 | — | $3.2B |
| 股东权益账面价值 | $779.3M | $-1.8B |
| 总资产 | $2.2B | $1.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHFICO
| Q4 25 | $429.5M | $162.0M | ||
| Q3 25 | $463.4M | $134.1M | ||
| Q2 25 | $342.1M | $189.0M | ||
| Q1 25 | $260.9M | $146.6M | ||
| Q4 24 | $290.8M | $184.3M | ||
| Q3 24 | $350.3M | $150.7M | ||
| Q2 24 | $327.7M | $156.0M | ||
| Q1 24 | $337.3M | $135.7M |
总债务ASTHFICO
| Q4 25 | — | $3.2B | ||
| Q3 25 | — | $3.1B | ||
| Q2 25 | — | $2.8B | ||
| Q1 25 | — | $2.5B | ||
| Q4 24 | — | $2.4B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.1B | ||
| Q1 24 | — | $2.0B |
股东权益ASTHFICO
| Q4 25 | $779.3M | $-1.8B | ||
| Q3 25 | $775.5M | $-1.7B | ||
| Q2 25 | $765.5M | $-1.4B | ||
| Q1 25 | $745.4M | $-1.1B | ||
| Q4 24 | $712.7M | $-1.1B | ||
| Q3 24 | $704.6M | $-962.7M | ||
| Q2 24 | $678.9M | $-829.3M | ||
| Q1 24 | $653.5M | $-735.7M |
总资产ASTHFICO
| Q4 25 | $2.2B | $1.9B | ||
| Q3 25 | $2.2B | $1.9B | ||
| Q2 25 | $1.4B | $1.9B | ||
| Q1 25 | $1.3B | $1.8B | ||
| Q4 24 | $1.4B | $1.7B | ||
| Q3 24 | $1.3B | $1.7B | ||
| Q2 24 | $1.3B | $1.7B | ||
| Q1 24 | $1.2B | $1.7B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $174.1M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $173.9M |
| 自由现金流率自由现金流/营收 | -0.6% | 34.0% |
| 资本支出强度资本支出/营收 | 0.3% | 0.0% |
| 现金转化率经营现金流/净利润 | -0.44× | 1.10× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $750.6M |
8季度趋势，按日历期对齐
经营现金流ASTHFICO
| Q4 25 | $-2.9M | $174.1M | ||
| Q3 25 | $10.0M | $223.7M | ||
| Q2 25 | $90.9M | $286.2M | ||
| Q1 25 | $16.6M | $74.9M | ||
| Q4 24 | $-10.9M | $194.0M | ||
| Q3 24 | $34.0M | $226.5M | ||
| Q2 24 | $23.2M | $213.3M | ||
| Q1 24 | $6.0M | $71.0M |
自由现金流ASTHFICO
| Q4 25 | $-6.0M | $173.9M | ||
| Q3 25 | $7.4M | $219.5M | ||
| Q2 25 | $89.5M | $284.4M | ||
| Q1 25 | $13.6M | $72.8M | ||
| Q4 24 | $-13.5M | $193.2M | ||
| Q3 24 | $31.7M | $224.7M | ||
| Q2 24 | $20.4M | $211.6M | ||
| Q1 24 | $5.6M | $67.0M |
自由现金流率ASTHFICO
| Q4 25 | -0.6% | 34.0% | ||
| Q3 25 | 0.8% | 42.6% | ||
| Q2 25 | 13.7% | 53.0% | ||
| Q1 25 | 2.2% | 14.6% | ||
| Q4 24 | -2.0% | 43.9% | ||
| Q3 24 | 6.6% | 49.5% | ||
| Q2 24 | 4.2% | 47.2% | ||
| Q1 24 | 1.4% | 15.4% |
资本支出强度ASTHFICO
| Q4 25 | 0.3% | 0.0% | ||
| Q3 25 | 0.3% | 0.8% | ||
| Q2 25 | 0.2% | 0.3% | ||
| Q1 25 | 0.5% | 0.4% | ||
| Q4 24 | 0.4% | 0.2% | ||
| Q3 24 | 0.5% | 0.4% | ||
| Q2 24 | 0.6% | 0.4% | ||
| Q1 24 | 0.1% | 0.9% |
现金转化率ASTHFICO
| Q4 25 | -0.44× | 1.10× | ||
| Q3 25 | 26.69× | 1.44× | ||
| Q2 25 | 9.65× | 1.57× | ||
| Q1 25 | 2.48× | 0.46× | ||
| Q4 24 | — | 1.27× | ||
| Q3 24 | 2.11× | 1.67× | ||
| Q2 24 | 1.21× | 1.69× | ||
| Q1 24 | 0.40× | 0.55× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
FICO
| Business To Business Scores | $248.6M | 49% |
| Saa S Products | $115.7M | 23% |
| Platform Software | $73.9M | 14% |
| Business To Consumer Scores | $55.9M | 11% |
| Technology Service | $19.2M | 4% |
